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Introduction
For years, radical nephrectomy was thought to be the
standard of curative treatment for renal cell carcinoma.
Once greater numbers of small, low-grade, incidental
tumors develop, there is greater need for the discus-
sion of surgical methods. In a series of reports, partial
nephrectomy has achieved equivalent cancer control
and obtained better preservation of renal function than
radical nephrectomy.1–5 The trend of treatment for
renal cell carcinoma has been changed to safer, more
efficient and less complicated methods. We need more
data to determine the positives and negatives of these
therapies. Recently, minimally invasive nephron-sparing
surgery has been reported to be a reliable cancer control
in the treatment of localized renal cell carcinoma.6–9
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We compared the outcome of partial nephrectomy
with radical nephrectomy in the treatment of T1N0M0
renal cell carcinoma.
Methods
We retrospectively collected data from 35 patients with
renal cell carcinoma who received partial nephrectomy
between July 1982 and December 2005. Among these
patients, 2 underwent partial nephrectomy laparoscop-
ically. In the meantime, data from 128 patients with
T1N0M0 renal cell carcinoma who underwent radical
nephrectomy were recorded. The chart records were
reviewed, and patients’ sex, age, tumor size, tumor
location, tumor characteristics, tumor cell type, intra-
operative vascular control, postoperative comorbidity,
concomitant surgical procedures, and follow-up peri-
ods were analyzed. The American Joint Committee on
Cancer revision of the tumor, node, metastasis (TNM)
system in 2002, 6th edition, was applied for tumor stag-
ing. The tumor location was classified as peripheral or
central type. The tumor characteristic was defined as
solitary or multifocal. Intraoperative vascular control
was defined as arterial, both or none.
During partial nephrectomy, preoperative ureteral
catheter placement was performed for the intraopera-
tive detection of the collecting system. We routinely
used intraoperative sonography to identify the tumor
margin. Frozen section was not routinely performed.
Postoperative comprehensive renal function tests were
performed in some patients in the partial nephrectomy
group. Serum creatinine levels were recorded in both
groups.
We used Yate’s contingency correction in the analysis
of gender and Mann–Whitney U test in the compari-
son of age, tumor size, follow-up duration, and pre-
and postoperative serum creatinine levels. Log-rank
test was performed in the surviving analysis. Analyses
were performed using SPSS version 10.1 (SPSS Inc.,
Chicago, IL, USA).
Results
Twenty patients in the partial nephrectomy group were
pathologic grade 1; another 10 patients were grade 1–2,
and the other 5 were grade 2. There was no grade 
3 disease. Sixteen patients were clinical stage T1a,
another 17 were T1b, and the other 2 were T2. In the
radical nephrectomy group, 75 patients were grade 1,
30 patients were grade 2, another 21 patients were
grade 1–2, and the other 2 patients were grade 3.
Fifty-seven patients had T1a disease, and the other
71 had T1b. There was no local recurrence or distant
metastasis in the partial nephrectomy group. Nine
patients died during follow-up in the partial nephrec-
tomy group. Thirteen patients died due to disease in
the radical nephrectomy group. Overall, 24 patients died
during follow-up in the radical nephrectomy group.
Two patients survived with disease in this group.
Table 1 demonstrates the baseline data of the 
2 groups. The sex distribution was insignificant between
the 2 groups. Partial nephrectomy patients exhibited
older age (65.8 vs. 61.1 years, p = 0.018), and the aver-
age tumor size was smaller than that in the radical
nephrectomy group (3.8 vs. 4.5 cm, p = 0.003). The
5-year overall survival was 85.0%, compared with 91.4%
in the radical nephrectomy group (p=0.126) (Figure 1).
The disease-free survival in the partial nephrectomy
group was 100%. From analysis of the tumor location
and tumor characteristic in the partial nephrectomy
group, 31 (88.6%) patients had peripheral type tumors
and the other 4 patients had central, medial type tumors.
Two (5.7%) patients had 2 tumor foci, and the other
33 had solitary tumors. Among the partial nephrectomy
cases, 28 (79.5%) were clear cell type, 3 (8.8%) were
papillary cell type, 2 (5.9%) were chromophobe type,
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Table 1. Variable differences between partial nephrectomy and radical nephrectomy groups*
Partial nephrectomy Radical nephrectomy
p
(n = 35) (n = 128)
Sex 0.916†
Female 10 (28.6) 39 (30.5)
Male 25 (71.4) 89 (69.5)
Age (yr) 65.8 ± 10.5 (42–82) 61.1 ± 11.3 (30–83) 0.018‡
Tumor size (cm) 3.8 ± 1.3 (1.5–7.0) 4.5 ± 1.4 (1.0–6.5) 0.003‡
Follow-up duration (yr) 5.6 ± 4.7 (0.05–17.99) 6.9 ± 5.2 (0.01–22.25) 0.205‡
*Data presented as n (%) or mean ± standard deviation (range); †Yate’s contingency correction; ‡Mann–Whitney U test.
1 (2.9%) was mixed clear and papillary cell type, and 
1 (2.9%) was mixed oncocytic and chromophobe type.
In the radical nephrectomy group, 109 (85.1%) were
clear cell type, 6 (4.7%) were papillary cell type, 10
(7.8%) were chromophobe type, 2 (1.6%) were mixed
clear and papillary cell type, and the other 1 (0.8%) was
mixed clear and sarcomatoid cell type.
Vascular control has been widely used during partial
nephrectomy, especially when tumor approach is diffi-
cult or when suturing.5 In our study, vascular clamping
was performed in 25 (70.5%) patients. Arterial clamping
was performed in 23 patients, and the other 2 received
both arterial and venous clamp. In the partial nephrec-
tomy group, postoperative serum creatinine increased to
> 2.0 mg/dL in 5 (14.3%) patients. No patients needed
dialysis during follow-up.
Seven (20%) patients received postoperative compre-
hensive renal function tests in the period of 3 months
to 12 months postoperatively. The function of the oper-
ated kidney ranged from 53 to 189 mL/min (mean,
114.6 ± 34.2 mL/min). In the radical nephrectomy
group, 6 (4.7%) patients with preoperative chronic re-
nal insufficiency status received immediate hemodial-
ysis postoperatively. There was no difference between
the 2 groups in the comparison of preoperative and
postoperative mean serum creatinine (1.3 and 1.7 vs.
1.2 and 1.7 mg/dL, respectively) (Table 2).
Discussion
Previous results of partial nephrectomy have established
its standard place in the treatment of localized, small
renal cell carcinoma.1–5,7 In our series, no disease recur-
rence or distant metastasis developed in the partial ne-
phrectomy group, although the 5-year overall survival
was only 85%, compared with 91% in the radical ne-
phrectomy group. The disease-specific survival was
excellent. Our result in radical nephrectomy was simi-
lar to those of other reported series, but the overall
survival was poorer in the partial nephrectomy group,
although there was no statistical significance.1,2,10 The
shortness of the follow-up duration in the partial ne-
phrectomy group may have contributed to this effect.
Three major complications (8.6%) occurred, and 2
of them resulted in early mortality in our early experi-
ence of partial nephrectomy. One was a 76-year-old
woman with old stroke and chronic renal insufficiency.
She died of aspiration pneumonia with sepsis on the
19th postoperative day. The other one, a 73-year-old
man, had acute cholecystitis and 4-cm right renal tumor.
He received cholecystectomy and partial nephrectomy
simultaneously. Postoperative poorly-controlled cholan-
gitis and aspiration pneumonia developed, and he died
of sepsis on the 6th postoperative day. The third com-
plication was a renal fistula, which was successfully
treated with prolonged internal drainage and debride-
ment. In the comparison of complication rates, our
series is similar to other reports.1,6
Partial nephrectomy has been reported to be ben-
eficial in preserving postoperative renal function in
selected patients.11–15 Serum creatinine is used mostly
in the comparison of perioperative renal function
changes.5,6 We did not find significant improvement
in the comparison of perioperative serum creatinine
between the 2 groups. Additionally, we performed com-
prehensive renal function tests postoperatively in the
partial nephrectomy group, and it showed effective renal
function preservation with an average of 114.6 mL/min
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Table 2. Perioperative serum creatinine changes between partial nephrectomy and radical nephrectomy groups*
Partial nephrectomy (n = 35) Radical nephrectomy (n = 86) p†
Creatinine (mg/dL)
Preoperative 1.3 ± 0.6 (0.8–4.2) 1.2 ± 0.6 (0.9–6.3) 0.277
Postoperative 1.7 ± 1.2 (0.8–5.1) 1.7 ± 1.1 (0.9–7.1) 0.103
*Data presented as mean ± standard deviation (range); †Mann–Whitney U test.
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Figure 1. Log rank test overall survival curve of partial nephrectomy
and radical nephrectomy groups.
in 7 patients. Although there was a lack of perioperative
comparison and fewer cases, this study still empha-
sized the advantage of partial nephrectomy in the
preservation of renal function.
The indications for partial nephrectomy have been
expanded due to the relatively safe and well-documented
surgical experience.5 In our series, only 6 patients
reached the criteria of absolute indication, including
solitary functioning kidney in 4 patients and multifocal
tumors in 2 patients. Size, location and tumor charac-
teristic (exophytic or endophytic) are the major factors
we were concerned about preoperatively. Age and per-
formance status were not the definitive contributors.
Although we lacked the American Society of Anesthe-
siologists class score or Eastern Cooperative Oncology
Group performance status data reported for other series,
it showed the age was larger in the partial nephrectomy
group than in the radical nephrectomy group.2,11
With regard to the surgical technique, vascular con-
trol and renal hypothermia have been considered as
standard procedures in performing partial nephrec-
tomy.5 Both vascular control and renal hypothermia
may decrease blood loss in larger tumors and prevent
reperfusion injury. Surface cooling alone has been rec-
ommended and provides safe ischemic effect without
permanent injury.16 We found that around 30% of the
partial nephrectomy patients in our study did not have
clamping of renal vessels through meticulous patient
selection. Gill et al6 and Novick7 reported their expe-
rience in partial nephrectomy. Laparoscopic partial
nephrectomy achieved excellent outcome, and the com-
plication rate was acceptable.6,7 A laparoscopic tech-
nique seems feasible in partial nephrectomy, but is still
a skills-oriented procedure. It should be performed only
in selected cases by well-experienced surgeons. The
da Vinci system has been introduced into our institute,
and robot-assisted partial nephrectomy is now per-
formed on a regular basis. Although the results have
not been included in this study, the outcome is inspir-
ing in our limited experience. The robot decreases the
technical difficulty in extracorporeal suturing and per-
mits urologists to complete the complex procedures
within reasonable warm-ischemia time. Kaul et al17 and
Caruso et al18 have reported their appreciated outcome
in their early experience. On the other hand, the cost of
robotic surgery remains a limitation to popularization.
Other minimally invasive treatments for localized
renal tumor have been established, including cryoab-
lation, radiofrequency ablation, high-intensity focused
ultrasound, and microwave thermotherapy.8,9,19,20 The
existing data support the efficacy of cryotherapy and
radiofrequency ablation in selected patients, especially
for small, exophytic, peripheral tumors in the elderly
population. However, using these therapies is contro-
versial, owing to the concern of completeness of tumor
removal.
In conclusion, our review showed excellent onco-
logic control with partial nephrectomy in the treatment
of localized, small renal cell carcinoma in selected cases.
The benefit of renal function preservation can also be
obtained from partial nephrectomy.
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